| Degradability of chitosan micro/nanoparticles for pulmonary drug delivery N Islam, I Dmour, MO Taha Heliyon 5 (5), e01684, 2019 | 200 | 2019 |
| Stable chitosan-based nanoparticles using polyphosphoric acid or hexametaphosphate for tandem ionotropic/covalent crosslinking and subsequent investigation as novel vehicles … RM Saeed, I Dmour, MO Taha Frontiers in bioengineering and biotechnology 8, 4, 2020 | 107 | 2020 |
| Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteers NM Najib, N Idkaidek, A Adel, I Admour, REB Astigarraga, GD Nucci, ... Biopharmaceutics & drug disposition 24 (5), 183-189, 2003 | 61 | 2003 |
| Bioequivalence evaluation of two brands of metformin 500 mg tablets (Dialon® & Glucophage®) – in healthy human volunteers N Najib, N Idkaidek, M Beshtawi, M Bader, I Admour, SM Alam, Q Zaman, ... Biopharmaceutics & drug disposition 23 (7), 301-306, 2002 | 54 | 2002 |
| Natural and semisynthetic polymers in pharmaceutical nanotechnology I Dmour, MO Taha Organic materials as smart nanocarriers for drug delivery, 35-100, 2018 | 50 | 2018 |
| Recent advances on chitosan as an adjuvant for vaccine delivery I Dmour, N Islam International Journal of Biological Macromolecules 200, 498-519, 2022 | 49 | 2022 |
| Alginates: versatile polymers in biomedical applications and therapeutics MS Hasnain, AK Nayak CRC Press, 2019 | 36 | 2019 |
| Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles I Dmour, MO Taha International Journal of Pharmaceutics 529 (Issues 1–2), 15–31, 2017 | 28 | 2017 |
| Bioequivalence assessment of Azomycin®(Julphar, UAE) as compared to Zithromax®(Pfizer, USA)—two brands of azithromycin—in healthy human volunteers NM Najib, N Idkaidek, IE Ghanem, I Admour, S Mahmood Alam, Q Zaman, ... Biopharmaceutics & drug disposition 22 (1), 15-21, 2001 | 27 | 2001 |
| Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide® & Diamicron®) — in healthy human volunteers N Najib, N Idkaidek, M Beshtawi, M Bader, I Admour, SM Alam, Q Zaman, ... Biopharmaceutics & drug disposition 23 (5), 197-202, 2002 | 25 | 2002 |
| Bioequivalence evaluation of two brands of enalapril 20mg tablets (narapril and renitec) in healthy human volunteers NM Najib, N Idkaidek, A Adel, I Admour, REB Astigarraga, GD Nucci, ... Biopharmaceutics & drug disposition 24 (7), 315-320, 2003 | 22 | 2003 |
| Bioequivalence evaluation of two brands of aceclofenac 100mg tablets (Aceclofar and Bristaflam) in healthy human volunteers N Najib, N Idkaidek, M Beshtawi, M Bader, I Admour, SM Alam, Q Zaman, ... Biopharmaceutics & drug disposition 25 (3), 103-108, 2004 | 20 | 2004 |
| Bioequivalence evaluation of two brands of furosemide 40mg tablets (Salurin and Lasix) in healthy human volunteers N Najib, N Idkaidek, M Beshtawi, M Bader, I Admour, SM Alam, Q Zaman, ... Biopharmaceutics & drug disposition 24 (6), 245-249, 2003 | 14 | 2003 |
| Bioequivalence assessment of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK)‐Two brands of Acyclovir‐in healthy human volunteers NM Najib, N Idkaidek, M Beshtawi, B Mohammed, I Admour, SM Alam, ... Biopharmaceutics & drug disposition 26 (1), 7-12, 2005 | 13 | 2005 |
| Comparison of two cyclosporine formulations in healthy Middle Eastern volunteers: bioequivalence of the new Sigmasporin Microoral and Sandimmun Neoral NM Najib, N Idkaidek, A Adel, B Mohammed, S Al-Masri, SM Alam, ... European journal of pharmaceutics and biopharmaceutics 55 (1), 67-70, 2003 | 12 | 2003 |
| Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers NM Najib, N Idkaidek, A Adel, B Mohammed, S Al‐Masri, I Admour, ... Biopharmaceutics & drug disposition 26 (1), 1-5, 2005 | 11 | 2005 |
| Degradability of chitosan micro/nanoparticles for pulmonary drug delivery. Heliyon 5: e01684 N Islam, I Dmour, MO Taha | 8 | 2019 |
| UPLC-MS Profile and Anti-Proliferative Activity of the Berries of an Aggressive Wild-Growing Weed: Solanum elaeagnifolium Cav. (Solanaceae) KD Al-Hamaideh, I Dmour, T El-Elimat, FU Afifi Tropical Journal of Natural Product Research, 2020 | 7* | 2020 |
| Degradability of chitosan micro/nanoparticles for pulmonary drug delivery. Heliyon, 5 (5), 1-9 N Islam, I Dmour, MO Taha | 4 | 2019 |
| Application of Dual Ionic /Covalent Crosslinking in Lecithin/ Chitosan Nanoparticles and their Evaluation as Drug Delivery System I DMOUR, H MUTI ACTA POLONIAE PHARMACEUTICA – DRUG RESEARCH 78 (1), 83-96, 2021 | 3 | 2021 |
Nasir IdkaidekUniversity of Petra, Faculty of Pharmacy and Medical SciencesVerified email at uop.edu.jo
